Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment.

Published in: Journal of oncology (2018)

Our findings implicate that the PLK1 inhibition and immunotherapy combination may achieve a synergistic antitumor efficacy.

Keyphrases